Veronika Bachanova

25PUBLICATIONS
149CO-AUTHORS
Haematological tumoursLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 24, 2026
Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma.

|Apr 27, 2026
Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy.

|Oct 10, 2025
CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma: lessons learned from clinical trials and real world evidence.

Supriya Gupta, Veronika Bachanova

|Aug 23, 2025
The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia.

Timothy E O'Connor, Chenyu Lin, Gregory W Roloff

|Apr 17, 2025
CAR-T for multiple myeloma: practice pearls.

Daniel O'Leary, Veronika Bachanova

|Dec 10, 2024
Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis.

Peter A Riedell, Connor B Grady, Loretta J Nastoupil

Pageof 5

Frequent Collaborators

4 joint publications

Daniel Weisdorf

4 joint publications

Joseph Maakaron

3 joint publications

Margaret L MacMillan

3 joint publications

Nuttavut Sumransub